Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Macroscopic thermal entanglement due to radiation pressure.
Ferreira A, Guerreiro A, Vedral V. Ferreira A, et al. Among authors: guerreiro a. Phys Rev Lett. 2006 Feb 17;96(6):060407. doi: 10.1103/PhysRevLett.96.060407. Epub 2006 Feb 17. Phys Rev Lett. 2006. PMID: 16605972 Free article.
Hydrogen sensing via anomalous optical absorption of palladium-based metamaterials.
Hierro-Rodriguez A, Leite IT, Rocha-Rodrigues P, Fernandes P, Araujo JP, Jorge PA, Santos JL, Teixeira JM, Guerreiro A. Hierro-Rodriguez A, et al. Among authors: guerreiro a. Nanotechnology. 2016 May 6;27(18):185501. doi: 10.1088/0957-4484/27/18/185501. Epub 2016 Mar 22. Nanotechnology. 2016. PMID: 27003717
Optomechanical entanglement between a movable mirror and a cavity field.
Vitali D, Gigan S, Ferreira A, Böhm HR, Tombesi P, Guerreiro A, Vedral V, Zeilinger A, Aspelmeyer M. Vitali D, et al. Among authors: guerreiro a. Phys Rev Lett. 2007 Jan 19;98(3):030405. doi: 10.1103/PhysRevLett.98.030405. Epub 2007 Jan 19. Phys Rev Lett. 2007. PMID: 17358666
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
210 results